Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452466 | 0.75 | — | — | |
| Ethyne SCHEMBL28308838 | 0.74 | CA12 (0.42) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL20212033 | 0.72 | TSHR (0.46) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL27566038 | 0.72 | TSHR (0.46) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL896 | 0.72 | TSHR (0.46) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL3904839 | 0.72 | TSHR (0.46) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL15486339 | 0.72 | DNM1 (0.67) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL19850597 | 0.72 | — | — | |
| Cyanide SCHEMBL1998468 | 0.72 | CA12 (0.40) | TSHRLMNADNM1THRBCA12 | |
| SCHEMBL464950 | 0.69 | TSHR (0.36) | TSHRLMNADNM1THRBCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111712529-A | Method and composition for preparing thermosetting poly (arylene ether) copolymer | 沙特基础工业全球技术有限公司 | 2020-09-25 | — | — | CN | claimed |
| EP-2921499-B1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACIDS | TAKEDA PHARMACEUTICALS CO (JP) | 2020-01-22 | — | — | EP | claimed |
| EP-3571241-A1 | PROCESS FOR THE MANUFACTURE OF THERMOSETTING POLY(ARYLENE ETHER) COPOLYMER AND COMPOSITIONS | SABIC Global Technologies B.V. (NL) | 2019-11-27 | — | — | EP | claimed |
| CN-110317197-A | A kind of aminomethyl substituted silibinin derivative and its preparation method and application | 天士力医药集团股份有限公司 | 2019-10-11 | — | — | CN | claimed |
| WO-2019116309-A1 | PROCESS FOR THE MANUFACTURE OF THERMOSETTING POLY(ARYLENE ETHER) COPOLYMER AND COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-06-20 | — | — | WO | claimed |
| EP-1112281-B1 | PTERIDINE NUCLEOTIDE ANALOGS | US GOV HEALTH & HUMAN SERV (US) | 2005-11-23 | — | — | EP | claimed |
| EP-1112281-A1 | PTERIDINE NUCLEOTIDE ANALOGS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) | 2001-07-04 | — | — | EP | claimed |
| WO-2000014101-A1 | PTERIDINE NUCLEOTIDE ANALOGS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-03-16 | — | — | WO | claimed |
| EP-0759927-B1 | PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES | US GOV HEALTH & HUMAN SERV (US) | 1998-06-24 | — | — | EP | claimed |
| EP-0759927-A1 | PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-03-05 | — | — | EP | claimed |
| US-5525711-A | MONOMERS FOR DNA AMPLIFICATION PROCEDURES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-06-11 | — | — | US | claimed |
| WO-1995031469-A1 | PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0648220-A1 | DEUTERATED NUCLEOSIDES | CHATTOPADHYAYA, Jyoti (SE) | 1995-04-19 | — | — | EP | claimed |
| WO-1993025566-A1 | DEUTERATED NUCLEOSIDES | CHATTOPADHYAYA JYOTI (SE) | 1993-12-23 | — | — | WO | claimed |
| US-20230119227-A1 | OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT | INTEGRATED DNA TECHNOLOGIES, INC. | 2023-04-20 | — | — | US | disclosed |
| CN-111712529-B | Method and composition for preparing thermosetting poly (arylene ether) copolymer | 高新特殊工程塑料全球技术有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-111712529-B | Method and composition for preparing thermosetting poly (arylene ether) copolymer | 高新特殊工程塑料全球技术有限公司 | 2023-02-28 | — | — | CN | disclosed |
| EP-0196101-B1 | PURIFICATION OF SYNTHETIC OLIGOMERS | CHIRON CORP (US) | 1991-05-02 | — | — | EP | disclosed |
| EP-0398391-A1 | 0,0'-Dicyanoethyl-phosphoramidites, a process for their preparation and their use in phosphorylation reactions | CHIRON CORPORATION (US) | 1990-11-22 | — | — | EP | disclosed |
| EP-0196101-A2 | Purification of synthetic oligomers | CHIRON CORPORATION (US) | 1986-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119227-A1 | OLIGONUCLEOTIDE SYNTHESIS ON SOLID SUPPORT | RNGTT, SSU72, NSUN2 | TSHR 2212/4885LMNA 1861/4885DNM1 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.